Barclays downgrades Dr. Martens to underweight, cuts price target
Summary
Barclays has lowered its investment rating on Dr. Martens to underweight. Alongside this change, the financial institution also reduced its price target for the footwear brand.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.